Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • india

    Tag: india

    You Searched For "india"
    Union Health Minister asked not to receive donations from JnJ for TB Control Program

    Union Health Minister asked not to receive donations from JnJ for TB Control Program

    Medical Dialogues Bureau3 May 2019 9:15 AM IST
    Recently, Johnson & Johnson (JnJ) had announced to provide an additional 10,000 courses of tuberculosis drug bedaquiline (BDQ) to the Indian...
    Using AI to detect mental health disorders likely to be counterproductive

    Using AI to detect mental health disorders likely to be counterproductive

    Medical Dialogues Bureau30 April 2019 9:00 AM IST
    AI-based vocal analytics may allow patients to detect the disease at home by just speaking into a smartphone application, eliminating the need to be...
    Serdia Pharma launches nationwide campaign for angina awareness

    Serdia Pharma launches nationwide campaign for angina awareness

    Medical Dialogues Bureau28 April 2019 9:25 AM IST
    As a part of this global initiative, SERDIA Pharmaceuticals has launched a comprehensive programme in India: 'Angina Awareness India'.New Delhi:...
    All medical devices sold in India to be CDSCO certified: What is Means

    All medical devices sold in India to be CDSCO certified: What is Means

    Meghna A Singhania18 April 2019 2:59 PM IST
    Once this notification comes into effect, the manufacture and sale of all medical devices would have to be certified by the Central Drugs Standard...
    Cipla acquires 30 percent stake in Brandmed for Rs 32 crore

    Cipla acquires 30 percent stake in Brandmed for Rs 32 crore

    Garima18 April 2019 9:15 AM IST
    The acquisition of Brandmed is expected to complete by May 31. The transaction worth Rs 32 crore will be executed by the company's South African arm...
    Intas Pharma launches Cancer Drug Eleftha for Rs 19,995; 65 percent lower than market rate

    Intas Pharma launches Cancer Drug Eleftha for Rs 19,995; 65 percent lower than market rate

    Meghna A Singhania11 April 2019 10:50 AM IST
    Mumbai: In a move that will provide relief to cancer patients, drugmaker Intas Pharmaceuticals has recently announced the launch of Trastuzumab...
    Alcon sees India as key growth engine for business; to focus on surgical, vision care, dry eye portfolios

    Alcon sees India as key growth engine for business; to focus on surgical, vision care, dry eye portfolios

    Medical Dialogues Bureau11 April 2019 9:05 AM IST
    With the completion of the spin-off, Alcon will become the largest eye care devices company in the world, he added.New Delhi: Global eye care major...
    Government to ban export of anti-rabies vaccine; Bharat Biotech biz likely to take hit : Report

    Government to ban export of anti-rabies vaccine; Bharat Biotech biz likely to take hit : Report

    Meghna A Singhania7 April 2019 11:00 AM IST
    New Delhi: Hyderabad based biotechnology firm, Bharat Biotech is likely to face setback as the Government plans to impose a ban on export of...
    Moopen backed Aster DM to infuse about Rs 1000 crore in Indian Hospitals by 2021: Report

    Moopen backed Aster DM to infuse about Rs 1000 crore in Indian Hospitals by 2021: Report

    Garima6 April 2019 11:30 AM IST
    Kochi: In a move to cater to healthcare facilities, Aster DM Healthcare is planning to infuse about Rs 1000 crore in India by 2021. According to...
    Emcure launches generic Eribulin at 40 percent lower price in India

    Emcure launches generic Eribulin at 40 percent lower price in India

    Farhat Nasim4 April 2019 9:30 AM IST
    Emcure Pharmaceuticals will manufacture Eribulin at its plant at Hinjewadi in Pune and market it at a cost which will be approximately 40 per cent...
    February has been a month of achievements, robust initiatives and success at AMRI Hospitals

    February has been a month of achievements, robust initiatives and success at AMRI Hospitals

    Medical Dialogues Bureau26 March 2019 9:05 AM IST
    New Delhi: With an utmost commitment towards delivering the best medical services, AMRI Hospitals, Bhubaneshwar, has always been at the forefront of...
    Union Health Ministry blocking Juul e cigarettes from coming into country: Report

    Union Health Ministry blocking Juul e cigarettes from coming into country: Report

    Meghna A Singhania18 March 2019 12:42 PM IST
    "Novel products such as 'Juul' are harmful and addictive and could potentially undermine our tobacco control efforts," Health Secretary Preeti Sudan...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok